India's Dr Reddy's may join race for generics ops of Germany's Merck - report |
|
|
|
Published
:
Mon, 05 Feb 2007 05:13
|
BOMBAY (XFN-ASIA) - Dr Reddy's Laboratories could join the race to acquire the generics business of German drugmaker Merck KGaA, Business Standard reported.'Merck's generic business is such a big asset and we cannot ignore it if it is up for sale,' it quoted a spokesman for Dr Reddy's as saying. 'We neither confirm our interest nor deny it.'The spokesman declined to comment on whether the company is in discussions with private equity funds for the acquisition, the newspaper said.Ranbaxy Laboratories and Cipla Ltd had already disclosed their interest in acquiring Merck's generics business in partnership with private equity funds, it noted.rc/
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
INTERVIEW Actavis hopes to acquire Merck KGaA's generic ops, to grow in Germany 